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Abstract
The 2017 World Workshop on the Classification of Periodontal and Peri-implant 
Diseases and Condition identified the gingivitis case by the presence of gingival 
inflammation at one or more sites and agreed upon bleeding on probing as the 
primary parameter for diagnosis of gingivitis. Clinical gingival health is generally 
associated with an inflammatory infiltrate and a host response consistent with 
homeostasis. The molecules that play a role in the pathogenesis are divided into 
two main groups: those derived from the subgingival microbiota (i.e., microbial 
virulence factors) and those derived from the host immune-inflammatory response. 
The immune system is essential for the maintenance of periodontal health and is 
categorized as innate immune system and the adaptive immune system. Innate 
immunity reflects the capacity of the host to defend against infectious attacks. 
Understanding the disease processes is important for the development of improved 
treatment strategies.
Keywords: pathogenesis, immune response, host susceptibility, 
inflammatory mediators
1. Introduction
Chronic gingivitis and periodontitis are chronic inflammatory lesions which 
display stages of inflammation as well as healing. The 2017 World Workshop 
on the Classification of Periodontal and Peri-implant Diseases and Condition 
identified the gingivitis case by the presence of gingival inflammation at one 
or more sites and agreed upon bleeding on probing as the primary parameter 
for diagnosis of gingivitis [1, 2]. Clinical gingival health is generally associ-
ated with an inflammatory infiltrate and a host response consistent with 
homeostasis.
The role of the immune response in periodontal destruction independent of 
bacteria was first described by Ivanyi et al. [3]. Later, Taubman et al. [4] studied the 
role of the immune response in a germ-free rat model of experimental periodontal 
disease and concluded that in order to control the disease, it would be crucial to 
enhance the protective “arm” of the immune response and suppress its destructive 
aspect [4]. The molecules that play a role in the pathogenesis are divided into two 
main groups: those derived from the subgingival microbiota (i.e., microbial viru-
lence factors) and those derived from the host immune-inflammatory response. 
Even though “periopathogenic bacteria” are still regarded as the main initiating 
agents, immune-inflammatory response of the host to these pathogens plays an 
important role in the pathogenesis of PD [5].
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2. Histopathology of gingivitis
The plaque biofilm causes most of the injury to the periodontal tissue through 
indirect mechanisms dependent on initiation and propagation of inflammatory 
host tissue reactions. The development of gingivitis is mainly the infiltration of 
the connective tissues by numerous defense cells, particularly neutrophils, macro-
phages, plasma cells, and lymphocytes. The accumulation of these defense cells and 
the extracellular release of their destructive enzymes cause destruction of collagen 
and subsequent proliferation of the junctional epithelium leading to vasodilata-
tion, increased vascular permeability, and hyperplastic gingival tissues. Clinically 
it appears as erythematous and edematous gingiva: the clinical appearance of 
gingivitis. The classic studies of Page and Schroeder [6] described the basic under-
standing of histologic changes that occur in the gingival tissues as the initial, early, 
established, and advanced gingival lesions. These are histologic descriptions only, 
primarily based on findings in experimental animals.
2.1 The initial lesion
The initial lesion develops within 2–4 days of the accumulation of plaque at a site 
free of plaque biofilm, which is evident microscopically since the gingival tissues 
always have characteristics of a low-grade chronic inflammatory response as a result 
of the continual presence of the subgingival biofilm. In other words, the initial 
lesion corresponds to the histologic picture that is evident in clinically healthy 
gingival tissues. This low-grade inflammation characterized by vasodilatation and 
increased vascular permeability along with upregulation of intercellular adhesion 
molecule-1 (ICAM-1) and E-selectin in gingival vasculature facilitates migration of 
neutrophils and monocytes into the connective tissue. This influx of fluid flow from 
the vessels increases the hydrostatic pressure in the local microcirculation resulting 
in increased gingival crevicular fluid (GCF) flow.
2.2 The early lesion
The early lesion corresponds to the early clinical signs of gingivitis and charac-
terized by erythematous clinical appearance of gingiva due to proliferation of capil-
laries and vasodilatation [7]. The predominant infiltrating cell types are neutrophils 
and T lymphocytes [7]. The basal cells of these epithelial structures proliferate 
apically resulting in edema of gingival tissues and deepening of gingival sulcus. 
The subgingival biofilm proliferates apically in this ecologic environment rendering 
plaque control difficult in these areas. The early gingival lesion may persist indefi-
nitely, or it may progress further.
2.3 The established lesion
The established lesion corresponds to clinical appearance referred to as “chronic 
gingivitis” and depends on many factors, such as composition and quantity of the 
plaque biofilm, host susceptibility factors, local and systemic risk factors. A study 
by Page and Schroeder [6] defined established lesion as mainly dominated by 
plasma cells with inflammatory cell infiltrate in connective tissues and destruction 
of collagen fibers. Neutrophils accumulated in the tissues, which are also a major 
source of matrix metalloproteinase-8 (MMP-8; neutrophil collagenase) and MMP-9 
(gelatinase B), release their lysosomal enzymes in the inflamed gingival tissues 
causing destruction of collagen bundles. This is followed by deepening of sulcus 
and formation of ulcerated pocket epithelium along the tooth surface resulting 
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in bleeding on probing which is a common feature of chronic gingivitis. These 
inflammatory changes are still completely reversible if effective plaque control is 
reinstituted.
2.4 The advanced lesion
The advanced lesion, as described by Page and Schroeder [6], marks the transi-
tion from gingivitis to periodontitis which is determined by many factors, such 
as composition and quantity of the biofilm, the host inflammatory response, and 
environmental and genetic risk factors.
3. Host susceptibility
The tooth has a unique situation in the mammalian biology and presents a 
special challenge to the immune system [8]. The marginal gingiva includes the 
epithelial and connective tissue attachment apparatus that provides a biological seal 
between the tooth and the gingival soft tissues.
The oral cavity is a unique microenvironment where millions of bacteria live 
in harmony with our host defense mechanisms, with the bacterial host balance 
maintained by the amount of bacterial load through our regular oral hygiene 
practices. It is therefore important to understand the cellular and molecular ele-
ments involved in the pathways from health to disease and from disease to repair 
and regeneration.
3.1 Role of host susceptibility in gingivitis
Even though the development of gingivitis after plaque accumulation is 
a universal finding, the rate or speed of development and the degree of the 
clinical inflammatory response are variables between individuals, even under 
similar plaque accumulation conditions [9]. The studies recognizing the role of 
host contributing to the pathology of periodontal disease was a major break-
through [10]. Various studies using the experimental gingivitis model showed 
13% of all individuals representing a “resistant” group [9, 11, 12]. The factors 
modulating the appearance of gingival inflammation in response to plaque 
accumulation are mainly exacerbated gingival response to plaque, including 
metabolic factors such as puberty and pregnancy; genetic factors such as Down 
syndrome; nutritional factors such as vitamin C deficiency; the intake of drugs 
such as those leading to gingival enlargement; systemic diseases such as leuke-
mia, immune deficiencies, and diabetes mellitus; and other conditions such as 
stress [9].
Gingivitis and periodontitis are the result of a coordinated action of clearly 
defined cellular players (proinflammatory and anti-inflammatory), which commu-
nicate with each other [13]. An inflammatory reaction can develop in two direc-
tions, either being destructive or regenerative depending on the bacterial antigen 
load and properties. If destructive, the innate immune reaction is followed by an 
adaptive or specific immune response, associated with the loss of tissue structure 
to create space for the immune process, and resolution of inflammation is associ-
ated with the regeneration of these structural hard and soft tissue components. It 
is therefore important to understand the cellular and molecular elements involved 
in the pathways from health to disease and from disease to repair and regeneration. 
The complex biological mechanisms occur in many phases from bacterial biofilm 
formation to periodontal regeneration and repair.
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3.2 Host cells in periodontal pathogenesis
The inflammatory infiltrate of periodontal disease (gingivitis and periodontitis) 
is characterized by polymorphonuclear leukocytes (PMNs), macrophages, lympho-
cytes, plasma cells [6]. The periodontium consists of cellular elements (epithelial cells, 
the periodontal ligament and gingival fibroblasts, and osteoblasts and osteoclasts) and 
molecular elements (extracellular matrix components such as the various collagens 
and the noncollagenous proteins). The interactions between these components deter-
mine the nature of periodontal disease activity, whether gingivitis or periodontitis.
3.2.1 Polymorphonuclear leukocytes (PMNs/neutrophils)
PMNs are the first line of defense against bacteria, and proper PMN functional-
ity is essential for protecting the integrity of the periodontium [14]. Neutrophils, 
present in clinically healthy gingival tissues, migrate through the intercellular 
spaces of the junctional epithelium into the sulcus [15, 16], in response to inflam-
matory chemotactic mediators such as IL-1, IL-8, or bacterial peptides (i.e., fMLP), 
and provide a “low-grade defense” against plaque bacteria [15, 17–19].
The proportion of neutrophils increases from 2% to 30% in modest inflam-
mation causing vascular permeability which facilitates leukocyte emigration and 
increases the flow of GCF into the pocket [15]. At the molecular level, the interac-
tion of adhesion molecules (e.g., ICAM-1) on endothelial and epithelial cells with β2 
integrins on neutrophils facilitates neutrophil migration.
In the tissues, neutrophils phagocytose microorganisms and produce reactive 
oxygen species (ROS) to kill within the cells by the formation of neutrophil extra-
cellular traps (NETs). NETs can be released by viable neutrophils and also following 
a form of programmed cell death called NETosis [20–24]. NETs are webs of com-
plexed nuclear and mitochondrial chromatin/DNA and antimicrobial molecules 
such as histones and antimicrobial peptides (AMPs) [25, 26]. In established lesions, 
neutrophils release toxic superoxides, free oxygen radicals, and tissue degrading 
enzymes contributing to local inflammation and tissue damage [27].
3.2.2 Macrophages
Macrophages are mononuclear cells mainly participating in the early or innate 
defense against microorganisms and in specific immunity through their antigen-
presenting function by releasing various cytokines. These cells present with varied 
phenotypes or subsets [28] and diverse functionality.
3.2.3 Natural killer cells
These killer cells are involved in the innate immune response by playing a vital 
role in host defenses against infected and malignant cells by producing cytokines such 
as TNF-α and interferon-g. These lymphocyte subgroup cells increase significantly 
from healthy human gingiva to diseased periodontal tissues [29, 30], in the immune 
response to plaque biofilm accumulation. Impaired lymphocyte function is also 
reported in various systemic conditions associated with periodontal diseases (e.g., 
Papillon-Lefèvre syndrome [31], Chédiak-Higashi syndrome [32], and smoking [33]).
3.2.4 Lymphocytes
Lymphocytes are one of the main types of immune cells with subsets T and 
B cells. When the innate or non-specific immunity is not able to cope with the 
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bacterial challenge, it activates the adaptive immune system by a group of cells, 
the T cells that have specific ability to present the bacterial antigens to the immune-
competent cells. T lymphocytes mainly contributes to periodontal pathogenesis 
by direct involvement in periodontal bone resorption [34, 35]. B cells, the second 
major lymphocyte subset, give rise to plasma cells that produce specific antibodies 
when triggered by the antigen and other regulatory cells. The number of B cells 
increases from health to gingivitis to periodontitis [6, 36], and its major role is in the 
pathogenesis of periodontitis.
4. Immune responses in periodontal pathogenesis
The immune systems are essential for the maintenance of periodontal health and 
are mainly categorized as innate immune system and the adaptive immune system 
(Figure 1). It is now widely studied that immune responses are complex biologic 
networks in which pathogen recognition, innate immunity, and adaptive immunity 
are integrated and mutually dependent [37]. They are also integrated with other 
systems, including the nervous system, hematopoiesis, and homeostasis as well as 
elements of tissue repair and regeneration [38] as shown in Figure 1.
4.1 Innate immunity
The term “innate immunity” refers to the elements of the immune response that 
are determined by inherited factors, that have limited specificity, and do not change 
or improve during an immune response or as a result of previous exposure to a 
pathogen. Innate immune mechanisms include a number of relatively non-specific 
mechanisms, including the barrier effect of an intact epithelium, saliva, and GCF 
(Figure 1). The keratinized epithelium of the sulcular and gingival epithelial tissues 
provides protection for the underlying periodontal tissue in addition to acting as 
a barrier against bacteria and their products [15, 39]. Saliva, secreted from three 
major salivary glands, plays an important role in preventing the attachment of 
bacteria to the dentition and the oral mucosal surfaces. These components include 
molecules that non-specifically inhibit the formation of the plaque biofilm by 
inhibiting adherence to oral surfaces and promoting agglutination (e.g., mucins), 
those that inhibit specific virulence factors (e.g., histatins that neutralize lipopoly-
saccharide (LPS)) and those that inhibit bacterial cell growth (e.g., lactoferrin) and 
Figure 1. 
Immune responses in periodontal pathogenesis.
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that may induce cell death [40, 41]. GCF originating from the postcapillary venules 
of the gingival plexus carries blood components like neutrophils, antibodies, and 
complement components which help in host defense mechanism [42].
Saliva, as part of innate immune response, is a key factor in protecting dental 
enamel, gingiva, and mucosa by flushing microbes and foodstuffs, buffering acids, 
remineralizing the tooth, providing antimicrobial activity, and permitting selective 
adhesion of commensal microorganisms to maintain a symbiotic environment in the 
dental biofilm [43]. The salivary flow rate—high or low—is characteristic of each 
individual and [44–47] may promote salivary clearance of microbes from the oral 
cavity. Saliva also contains varying amounts of immunomodulatory interleukin-1β, 
interleukin-17, and interleukin-23, although it is not known whether they contribute 
to innate immunity on mucosal surfaces of the oral environment [48].
4.1.1 Pathogen recognition and activation of innate response
The recognition of pathogenic microorganisms and the recruitment of effector 
cells (e.g., neutrophils) and molecules (e.g., the complement system) are central to 
effective innate immunity. Innate immune responses are orchestrated by a broad 
range of cytokines, chemokines, and cell surface receptors, and the stimulation of 
innate immunity leads to a state of inflammation. When microbes penetrate the 
periodontal tissues, specialized cells of immune system, macrophages and dendritic 
cells, express a range of pattern recognition receptors (PRRs) which interact with 
specific molecular structures on microorganisms called microbe-associated molecu-
lar patterns (MAMPs) activating the innate immune responses (Figure 2).
4.2 Bacterial biofilm formation and development of a host response
Biofilms have been defined as “organized microbial communities characterized 
by a first group of colonizers being irreversibly adhered to a substrate or interphase 
in a wet media and the rest being embedded in a matrix composed of extracellular 
polysaccharides produced by the bacteria.” The tooth surface provides a non-shed-
ding hard surface where bacteria can adhere and form complex biofilms [8, 49].
The combination of natural host defense mechanisms and oral hygiene practices 
of individuals helps to have a balanced coexistence of oral microbiota in a healthy 
oral cavity which can be disturbed by either quantitative (higher bacterial load) or 
qualitative (growth of pathogenic species) changes in the biofilm leading to early 
stages of gingivitis [49].
Figure 2. 
Microbial- and host-associated pathogenesis of periodontal disease.
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The epithelial attachment of tooth is a highly specialized structure where the 
junctional epithelial cells strongly attach to the tooth surface by a basal membrane, 
and hemidesmosomes providing the antibacterial defense mechanism by the high 
regeneration and desquamation rate and the continuous flow of gingival fluid 
through the gingival sulcus. The cells of the junctional epithelium with antibacterial 
proteins like human β-defensin 1 and chemokines along with intercellular adhesion 
molecule-1 (ICAM-1) and IL-8 help in the migration of PMN toward the gingival 
sulcus [8].
The protective function of the gingival epithelium is enhanced by keratinization, 
which helps resist abrasion. The gingival epithelium, as an innate immune barrier, 
is formed by interconnecting keratinocytes bridged one to another by cell adhesion 
molecules (CAMs) [50] which include integrins, mediating cell interactions with 
the extracellular matrix and basement membranes and contributing to cell-cell 
adhesion [51–53], as well as cadherins, which form tight contacts between cells [54]. 
The CAMs of the multilayered syncytium are susceptible to digestion by gingipains 
from Porphyromonas gingivalis, which could increase tissue permeability [55–58].
4.3 Innate immune response and gingivitis
Innate immunity is the first line of defense and the cells responsible for the 
innate immune response are mainly PMN, macrophages, and dendritic cells. 
Polymorphonuclear leukocytes (PMNs) are the first and predominant cells of the 
innate immune system in early gingivitis lesions [13].
The biofilm microbes on the tooth surfaces are recognized by the cells from the 
innate immunity through certain molecular patterns called pathogen-associated 
molecular patterns (PAMPs) which include lipopolysaccharide (LPS), peptidogly-
cans and lipoteichoic acids, N-formylmethionine, and lipoproteins. These molecules 
are recognized by pattern recognition receptors (PRRs) on the surface of PMNL 
and macrophages (Figure 2).
The two major families of PRRs that have been most extensively studied in the 
periodontium are the Toll-like receptor (TLRs) and the Nod-like receptors (NLRs) 
[59]. Toll-like receptors are unique receptors that recognize molecules that are 
broadly shared by microorganisms but are distinguishable from host molecules and 
can detect multiple pathogen-associated molecular patterns, including lipopoly-
saccharide, bacterial lipoproteins and lipoteichoic acids, flagellin, CpG DNA of 
bacteria and viruses, double-stranded RNA, and single-stranded viral RNA [60].
The TLR family currently consists of 10 known functional TLRs in humans 
[61, 62] in which TLR-1 through TLR-9 have been reported in the periodontium, 
in both health and disease [63]. When Toll-like receptors bind pathogen-associated 
molecular patterns, a series of intracellular events are initiated, leading to the 
production of cytokines, chemokines, and antimicrobial peptides (AMPs) [64]. 
Different Toll-like receptors induce different responses. For example, Toll-like 
receptors 1, 2, 4, 5, and 6 recognize products that are unique to bacteria and pre-
dominate in periodontal tissues, mainly in periodontitis [65] as shown in Figure 2.
4.4 Activation of adaptive immunity
If gingivitis persists without resolution, bacterial antigens are produced by 
lymphocytes, macrophages, and dendritic cells. Two different subgroups of lym-
phocytes, T lymphocytes and B lymphocytes, are released after being exposed 
with antigens by the innate immune cells. T cells are the effectors of cell-mediated 
immunity (delayed hypersensitivity), and B lymphocytes carry immunoglobulin 
molecules on their surface, which function as antigen receptors [66].
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Adaptive immunity provides a more focused defense against infections than 
innate immune responses, which is slower and dependent on complex interactions 
between antigen-presenting cells (APCs) and T and B lymphocytes, specifically 
“cytotoxic T cells” and antibodies. Many histologic studies of periodontal disease 
[6, 67] have suggested the importance of adaptive immune responses in periodon-
tal pathogenesis by the presence of leukocytes/neutrophils in the early stages of 
gingivitis and T cells in stable periodontal lesions. The T cells play a major role in 
maintaining tissue homeostasis against bacterial attack in plaque biofilm [68]. The 
transition from the established gingivitis lesion to periodontitis is mainly domi-
nated by T and B cells.
5. Host-derived inflammatory mediators
The molecules participating in the cellular interactions are mainly categorized 
as proinflammatory and anti-inflammatory, and the balance between these two 
types of molecules determines the tissue response and the initiation or progression 
of disease. The key proinflammatory mediators in periodontal disease pathogenesis 
are as follows.
5.1 Cytokines
Cytokines are produced by resident cells, such as epithelial cells and fibroblasts, 
by phagocytes (neutrophils and macrophages) in the acute and early chronic phases 
of inflammation, and by immune cells (lymphocytes) in established and advanced 
lesions [69]. Interleukin-1β and interleukin-6 are the main innate cytokines and, 
together with tumor necrosis factor alpha, are the first to appear in the periodontal 
disease pathogenesis pathways [70]. Cytokines are effective in very low concen-
trations and have pleiotropic effects (i.e., multiple biologic activities) on a large 
number of cell types.
Cytokines are key inflammatory mediators in periodontal disease [71]. They 
are soluble proteins acting as messengers and binding to specific receptors on 
target cells to initiate intracellular signaling cascades resulting in cellular changes 
by altered gene regulation [72, 73]. The genetic regulation leading to the secretion 
of proinflammatory cytokines from a variety of cells is generally dependent on 
the activation of nuclear factor kappa-B transcription [74, 75]. The nuclear factor 
kappa-B-regulated pathways are activated by pathogen-associated molecular pat-
terns, such as lipopolysaccharide, through the Toll-like receptor pathway [75].
5.1.1 Interleukin-1 family cytokines
The IL-1 family of cytokines comprises at least 11 members, including IL-1α, 
IL-1β, IL-1 receptor antagonist (IL-1Ra), IL-18, and IL-33 [71].
IL-1α is an intracellular protein, produced by monocytic, epithelial, osteoblastic 
cells found in the extracellular environment or in the circulation [76]. Studies have 
reported elevated IL-1α levels in GCF and gingival tissues in patients with gingivitis 
and periodontitis [77] and involved in the bone loss that is associated with inflam-
mation [78]. In recent nonhuman primate experiments, the use of a specific IL-1 
inhibitor resulted in significant reduction of periodontopathogen-induced attach-
ment loss, bone resorption, and inflammation [79] suggesting that IL-1 inhibitors 
might be useful in the management of periodontitis.
IL-1β produced by monocytes, macrophages, and neutrophils plays a key role 
in inflammation and immunity and along with lL-1α induces the synthesis and 
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secretion of other mediators that contribute to the inflammatory changes and tissue 
damage. IL-1β stimulates the synthesis of PGE2, platelet-activating factor, and 
nitrous oxide, resulting in vascular changes associated with inflammation [80]. 
Studies have shown increased concentration of IL-1β in GCF at sites affected by 
gingivitis [81] and tissue levels of IL-1β correlates with clinical periodontal disease 
severity [82]. IL-1β increases the expression of ICAM-1 on endothelial cells and 
stimulates the secretion of the chemokine CXCL8 (IL-8), thereby stimulating 
and facilitating the infiltration of neutrophils into the affected tissues [83]. Other 
members of IL family have more roles in the pathogenesis of periodontal disease.
5.1.2 Chemokines
Chemokines are chemotactic cytokines with an important role in the migration 
of phagocytic cells to the site of infection [84, 85]. Chemokines help in leukocyte 
recruitment in physiologic and pathologic conditions, which results in the chemo-
tactic migration of neutrophils through the periodontal tissues toward the site of 
the bacterial challenge in the periodontal pocket [86].
Chemokines are synthesized by a variety of cells including endothelial, epi-
thelial, and stromal cells, as well as leukocytes [87]. They are divided into two 
subfamilies: the CC subfamily and the CXC subfamily [88]. The chemokine CXCL8, 
also known as IL-8, has been found to be localized in the gingival tissues in areas 
of plaque biofilm accumulation and also in GCF112. Interaction between bacteria 
and keratinocytes results in the upregulation of IL-8 and ICAM-1 expression in the 
gingival epithelium, thereby stimulating neutrophil migration into the tissues and 
the gingival sulcus [89, 90].
Chemokines target leukocytes of the innate immune system, as well as lym-
phocytes of the adaptive immune system [91]. Chemokines play important roles 
in immune responses, repair, inflammation, and regulating osteoclast activity by 
influencing myeloid cell differentiation into osteoclasts, which may be of particular 
importance in the pathogenesis of periodontitis.
5.1.3 Tumor necrosis factor alpha
TNF-α is a molecularly distinct cytokine and a key inflammatory mediator in 
periodontal disease that shares many biologic activities with IL-1β [92]. Tumor 
necrosis factor alpha is a multi-effect cytokine that has many functions, from cell 
migration to tissue destruction. Tumor necrosis factor alpha impacts cell migration 
by inducing the upregulation of adhesion molecules and adhesion of neutrophils to 
the vessel wall, leading to extravasation. It also stimulates the production of chemo-
kines involved in cell migration to infected and inflamed sites [93–96]. The proin-
flammatory effects of TNF-α include the stimulation of endothelial cells to express 
selectins that facilitate the leukocyte recruitment, the activation of macrophage IL-1β 
production, and the induction of PGE2 by macrophages and gingival fibroblasts [97].
5.2 Lipid mediators of inflammation-prostaglandins and thromboxanes
Prostaglandins are derived from the hydrolysis of membrane phospholipids. 
Prostaglandin E2 (PGE2) and thromboxane B2 are lipid molecules produced by many 
host cells through the cyclooxygenase pathway, one of the two major paths of arachi-
donic acid metabolism. Inflamed gingiva synthesizes significantly larger amounts of 
prostaglandins when incubated with arachidonic acid than in healthy gingiva [98]. 
Within gingival lesions, prostaglandin E2 is mainly localized to macrophage-like cells 
and is secreted when stimulated with bacterial lipopolysaccharide [99].
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PGE2 induces the secretion of MMPs, as well as osteoclastic bone resorption, 
and it contributes significantly to the alveolar bone loss seen with all forms of 
periodontitis [100]. Prostaglandin E2 has biphasic actions on immune function. 
In high doses, it decreases the levels of IgG, but at low doses it has the potential to 
increase IgG. When combined with interleukin-4, low doses of prostaglandin E2 
induce a synergistic rise in IgG production, suggesting an immune-regulatory role 
for prostaglandin E2 [101].
5.3 Matrix metalloproteinase
Matrix metalloproteinases are a family of structurally related, but genetically 
distinct, enzymes that degrade extracellular matrix and basement membrane com-
ponents [102]. MMPs secreted by the majority of cell types in the periodontium, 
including fibroblasts, keratinocytes, endothelial cells, osteoclasts, neutrophils, and 
macrophages, are capable of degrading extracellular matrix molecules, including 
collagens [103, 104].
Most MMP activity in the periodontal tissues is derived from infiltrating 
inflammatory cells. In inflamed periodontal tissues, excessive quantities of MMPs 
are secreted by resident cells and neutrophils, resulting in the breakdown of the 
connective tissue matrix [105, 106] and leading to the development of collagen-
depleted areas within the connective tissues. The predominant MMPs in periodon-
titis, MMP-8 and MMP-9, secreted by neutrophils [107] are effective in degrading 
type 1 collagen, which is the most abundant collagen type in the periodontal 
ligament [108].
Matrix metalloproteinase activity is controlled by changes in the delicate 
balance between the expression and synthesis of matrix metalloproteinases and 
their major endogenous inhibitors, tissue inhibitors of matrix metalloproteinases 
[102]. The prolonged and excessive release of large quantities of MMPs in the 
periodontium leads to the significant breakdown of structural components of 
the connective tissues, thereby contributing to the clinical signs of disease. In 
periodontal disease, secretion of specific matrix metalloproteinases is stimulated 
or downregulated by various cytokines. The main stimulatory cytokines for 
matrix metalloproteinases are tumor necrosis factor alpha, interleukin-1, and 
 interleukin-6 [109].
6. Discussion
The immune and inflammatory processes that result from periodontal inflam-
mation in response to bacterial biofilm are complex and mediated by a large number 
of proinflammatory and anti-inflammatory cytokines and enzymes that function 
as a network of mediators. Many studies have confirmed that immune cells from 
patients with periodontal disease secrete higher quantities of proinflammatory 
cytokines than do cells from persons who are periodontally healthy [72]. These 
findings led to the concept of the “hyperinflammatory” or “hyperresponsive” trait 
in which certain individuals possess a hyperinflammatory phenotype that accounts 
for their increased susceptibility to chronic inflammatory conditions such as 
periodontitis [110].
Although plaque bacteria initiate the inflammatory response, most of the 
tissue damage results from the host response, which is influenced by genetic 
factors, as well as environmental and acquired risk factors [111]. An essential 
goal of interventions in inflammatory disease is the return of tissue to homeo-
stasis, by rapid elimination of invading leukocytes from a disease site [112]. 
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Inadequate resolution of inflammation and failure to return tissue to homeostasis 
result in neutrophil-mediated destruction and chronic inflammation [113], with 
destruction of both extracellular matrix and bone [114] leading to advanced 
periodontitis.
Recently efforts are undergoing to control inflammation by the use of 
pharmacologic agents that inhibit proinflammatory mediator pathways (e.g., 
nonsteroidal anti-inflammatory drugs) [115] which target cyclooxygenase 
1-dependent and cyclooxygenase 2-dependent pathways, inhibiting the gen-
eration of prostanoids. Accordingly, there is a need for the development of 
adjunctive agents for the management of periodontitis based on the current 
understanding of the etiology and pathobiology of periodontal disease. Host 
modulation therapy is an important emerging treatment strategy for managing 
all forms of periodontitis.
7. Conclusion
Periodontal diseases (gingivitis and periodontitis) are inflammatory diseases 
in which microbial etiologic factors induce a series of host responses that mediate 
inflammatory events. The maintenance of a healthy mucosal system is character-
ized by a continuous coordinated network of immune response that maintains 
the integrity of the tissue. Persistence of bacterial infection results in cellular and 
molecular modifications of the host response resulting in clinical manifestations of 
disease.
The presence of increased inflammation due to persistence of microbial 
pathogens with a failure of innate immunity systems will cause the shift of disease 
to a chronic state, later progressing to bone loss and periodontal tissue destruc-
tion. Even though persistent gingivitis is a risk factor for periodontal attachment 
loss, periodontitis is always a successor of gingivitis. However, studies in the last 
decade have brought significant understanding of the pathogenesis of periodontal 
disease by the recognition of dental plaque as a biofilm, discovery of new disease-
associated bacterial species, the role of risk factors in disease susceptibility, 
and advanced host-derived cellular and molecular mechanisms in periodontal 
destruction.
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